“Analisi Di Costo Di Pemetrexed Vs Docetaxel Nel Trattamento Di Seconda Linea Del Carcinoma Polmonare Non a Piccole Cellule”. Farmeconomia. Health Economics and Therapeutic Pathways 6, no. 2 (June 15, 2005): 119–126. Accessed February 15, 2026. https://journals.seedstm.com/index.php/FE/article/view/827.